CAS: 618-65-5; 2-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-2-yl)Oxy)Benzaldehyde

该化合物是一种自然形成的化学化合物,被归类为氟氯素甘蓝,主要来源于以其药性著称的基因肝素的植物物种.Hellicin的特征是结构成分,包括一种与糖味(通常是葡萄糖)相连的氟氯素脊椎,典型的葡萄糖.该化合物显示出各种生物活动,包括抗氧化剂,抗炎和潜在的抗微生物效应,因此对药理研究感兴趣.Helicin经常因其在传统医学中的作用及其在营养学中的潜在应用而接受研究.从物理特性来看,它一般是晶体系固体,可溶于极地溶剂,并可能显示浮质素典型的紫色吸收特性.其稳定性和再活性可能受到诸如pH和温度等环境因素的影响.总体来说,Hlicin是天然产品领域的一个重要化合物,有助于植物衍生物质在健康和健康方面的多种功能.

结构式图片

上下游产品

CAS号112289-85-7 2-(2,3,4,6-tetr... | CAS号14581-83-0 2'-FORMYLPHENYL... | CAS号14218-11-2 2-D-溴化吡喃葡糖-四苄酯 | CAS号90-02-8 水杨醛 | CAS号572-09-8 2,3,4,6-四乙酰氧基-a... | CAS号89-95-2 邻甲基苄醇 | CAS号53765-89-2 tetra-O-acetyl-... | CAS号4451-36-9 2,3,4,6-四-O-乙酰基... | CAS号14581-83-0 2'-FORMYLPHENYL... | CAS号2280-44-6 D-glucopyranose | CAS号89-95-2 邻甲基苄醇

合成工艺路线路线简述

    📜2-(2,3,4,6-Tetra-O-Benzoyl-β-D-Glucopyranosyloxy)Benzaldehyde置于potassium Carbonate体系中,用 甲醇,水 作为反应溶剂,化学反应 0.17H,以92%的收率获得产物绣线菊苷
    参考文献:相转移催化的d-葡萄糖基化:苯甲酰化的芳基β-D-吡喃葡萄糖苷和β-D-吡喃葡萄糖基取代的肉桂酸酯的合成
    标题:相转移催化的d-葡萄糖基化:苯甲酰化的芳基β-D-吡喃葡萄糖苷和β-D-吡喃葡萄糖基取代的肉桂酸酯的合成
    摘要:摘要用2,3,4,6-四-O-苯甲酰基-α-吡喃葡萄糖基溴化物进行相转移催化的螯合酚醛糖苷和取代的肉桂酸的d-葡萄糖基化反应,导致苯甲酰化的芳基β-吡喃葡萄糖苷和分别以非常好的吡喃糖苷类取代-β-D-葡萄糖基吡喃糖基肉桂酸酯和分别以非常好的产率分别形成取代的-β-D-葡萄糖基吡喃糖基肉桂酸酯.结果最终证实了较早的报道,即相转移方法需要碳水化合物部分中c-2或c-6处的非参与基团.在所有这些反应中,得到次要的副产物1,2,3,4,6-Penta-O-苯甲酰基-β-D-吡喃葡萄糖.讨论了相转移方法的可能机理.
    DOI:10.1016/0008-6215(87)80206-9

    海关参考信息

    专利信息


    专利号:US-2003050305-A1
    优先权日:2000-05-22
    标题:Thromboxane inhibitors, compositions and methods of use
    发明人:TEJADA INIGO SAENZ DE
    摘要:The present invention describes methods for treating or preventing sexual dysfunctions in males and females, and for enhancing sexual responses in males and females by administering a therapeutically effective amount of at least one thromboxane inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and/or at least one vasoactive agent. The male or female may preferably be diabetic. The present invention also provides novel compositions comprising at least one thromboxane inhibitor, and, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and, optionally, at least one therapeutic agent, such as, vasoactive agents, nonsteroidal antiinflanmmatory compounds (NSAIDs), selective cyclooxygenase-2 (COX-2) inhibitors, anticoagulants, angiotensin converting enzymes (ACE) inhibitors, angiotensin II receptor antagonists, renin inhibitors, and mixtures thereof. The present invention also provides methods for treating or preventing ischemic heart disorders, myocardial infarction, angina pectoris, stroke, migraine, cerebral hemorrhage, cardiac fatalities, transient ischaemic attacks, complications following organ transplants, coronary artery bypasses, angioplasty, endarterectomy, atherosclerosis, pulmonary embolism, bronchial asthma, bronchitis, pneumonia, circulatory shock of various organs, nephritis, graft rejection, cancerous metastases, pregnancy-induced hypertension, preeclampsia, eclampsia, thrombotic and thromboembolic disorders, intrauterine growth, gastrointestinal disorders, renal diseases and disorders, disorders resulting from elevated uric acid levels and dysmenorrhea, and for inhibiting platelet aggregation or platelet adhesion or relaxing smooth muscles.

    专利号:US-5175302-A
    优先权日:1987-07-13
    标 题 :Nucleophilic fluoroalkylation of aldehydes
    发明人:STAHLY G PATRICK
    权利人:ETHYL CORP
    摘要:Aryl difluoromethyl sulfone adds to aldehydes under phase transfer conditions to give novel substituted alcohols of the general formula n n RCH(OH)CF.sub.2 SO.sub.2 Ar (I) n n wherein R is an aryl, cycloaliphatic, sec- or tert-aliphatic, or heterocyclic group and Ar is an aryl group. The substituted alcohols of formula I are of particular utility as intermediates in the synthesis of a variety of useful end products. For example, the products of formula I may be utilized in desulfonylation reactions, oxidation reactions and fluorination reactions.

    专利号:US-4837327-A
    优先权日:1987-07-13
    标 题 :Process for nucleophilic fluoroalkylation of aldehydes
    发明人:STAHLY G PATRICK
    权利人:ETHYL CORP
    摘要:Aryl difluoromethyl sulfone adds to alkehydes under phase transfer conditions to give novel substituted alcohols of the general formula n n RCH(OH)CF.sub.2 SO.sub.2 Ar (I) n n wherein R is an aryl, cycloaliphatic, sec- or tert-aliphatic, or heterocyclic group and Ar is an aryl group. The substituted alcohols of formula I are of particular utility as intermediates in the synthesis of a variety of useful end products. For example, the products of formula I may be utilized in desulfonylation reactions, oxidation reactions and fluorination reactions.

    专利号:US-4999429-A
    优先权日:1989-01-09
    标 题 :Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives
    发明人:STAHLY G PATRICK
    权利人:ETHYL CORP
    摘要:Aryl difluoromethyl sulfone adds to aldehydes under phase transfer conditions to give novel substituted alcohols of the general formula n n RCH(OH)CF.sub.2 SO.sub.2 Ar (I) n n wherein R is an aryl, cycloaliphatic, sec- or tert-aliphatic, or heterocyclic group and Ar is an aryl group. The substituted alcohols of formula I are of particular utility as intermediates in the synthesis of a variety of useful end products. For example, the products of formula I may be utilized in desulfonylation reactions, oxidation reactions and fluorination reactions.

    专利号:US-9365532-B1
    优先权日:2011-02-14
    标题:Synthesis, composition and use of novel therapeutic and cosmetic Schiff base products formed by reaction of a carbonyl containing moeity with a transimination nucleophilic catalyst and the use of transimination nucleophilic catalysts to increase the rate at which carbonyl containing therapeutic and cosmetic actives form Schiff base products with biological amines
    发明人:ISAACMAN STEVEN
    权利人:ISAACMAN STEVEN; NANOMETICS LLC
    摘要:The present invention relates to the synthesis, composition and use of novel moieties formed by reacting a transimination nucleophilic catalyst, molecular or polymeric, with carbonyl-containing therapeutic or cosmetic moieties. The resultant Schiff base product is highly reactive towards transimination with a biological amine. The catalyst and carbonyl-containing moiety can be molecular or polymeric, and the resultant chemical and physical properties of the Schiff base products can be engineered by appropriate selection of said catalyst. The present invention also relates to the synthesis, composition and use of novel moieties that are used as actives in sunless tanning preparations. The present invention also relates to the use of transimination nucleophilic catalysts to increase the rate at which a carbonyl-containing moiety reacts with a biological amine. The present invention also relates to the use of transimination nucleophilic catalysts to increase the rate and efficacy of commercial sunless tanning preparations. Improvements on stability and efficacy of said preparations are disclosed. While the invention has been described in terms of its preferred embodiments, those skilled in the art will recognize that the invention can be practiced with modification within the spirit and scope of the appended claims. Accordingly, the present invention should not be limited to the embodiments as described above, but should further include all modifications and equivalents thereof within the spirit and scope of the description provided herein.

    专利号:CN-205893398-U
    优先权日:2016-07-28
    标题:A platinum-plated anode rod for electrolytic synthesis of ammonium persulfate

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Zimmer, R.; Trawny, D., Science of Synthesis Knowledge Updates, (2013) 4, 161.
    参考文献:10.1007/pl00007835
    摘要:Fernández O. Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J Neurol. 2002 Jan;249(1):1–8. doi: 10.1007/pl00007835.
    参考文献:10.1385/endo:23:2-3:093
    摘要:Christ GJ, Lue T. Physiology and biochemistry of erections. Endocrine. 2004 Mar;23(2-3):93–100. doi: 10.1385/endo:23:2-3:093.
    参考文献:10.1385/endo:23:2-3:135
    摘要:Shabsigh R. Therapy of ED: PDE-5 Inhibitors. Endocrine. 2004 Mar;23(2-3):135–41. doi: 10.1385/endo:23:2-3:135.
    参考文献:10.1038/s41585-019-0210-6
    摘要:Allen MS. Physical activity as an adjunct treatment for erectile dysfunction. Nat Rev Urol. 2019 Sep;16(9):553–62. doi: 10.1038/s41585-019-0210-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知